A number of clinical studies have demonstrated that higher expression of VDR is positively correlated with better prognosis or low TNM stage in breast cancer, colorectal cancer, papillary thyroid cancer, lung cancer, urothelial bladder cancer, and childhood solid tumors [13–18]. This evidence concerns the gene VDR and thyroid gland papillary carcinoma.